Упрощенная HTML-версия
treatment of neonatal sepsis / H. B. Jenson, В. H. Pollock. // Semin. Perinatol. -
1998.-Vo l. 22 .-P . 50-63.
393. Kaiser, R. The clinical and epidemiological profile of tick-borne encephalitis in
southernGermany 1994-98: a prospective study o f656 patients / R. Kaiser// Brain. -
1999.
- Vol. 122, pt. 11.-P . 2067-2078.
394. Kaiser, R. Tick-born encephalitis (TBE) in Germany and clinical course of disease /
R. Kaiser//Int. J. Med. Microbiol. - 2002. - Vol. 291, (suppl. 33 ) .-P . 58-61.
395. Keller, M. A. Passive Immunity in Prevention andTreatment of Infectious Diseases/
M. A. Keller, E. R. Stiehm // Clin. Microbiol. Rev. - 2000. - Vol. 13, № 4. -
P. 602-614.
396. Kreil, T. R. Pre- and postexposure protection by passive immunoglobulin but
no enhancement of infection with a flavivirus in a mouse model / T. R. Kreil,
М. M. Eibl // J. Virol. - 1997. - Vol. 71, № 4. - P. 2921-2927.
397. Kunitomi, A. Epstein-Barr virus-associated post-transplant lymphoproliferative
disorders presented as interstitial pneumonia; successful recovery with rituximab /
A. Kunitomi, N. Arima & T. Ishikawa // Haematologica. - 2007. - Vol. 92. -
P. 49-52.
• 398. Kunz, C. TBE vaccination and Austrian experience / C. Kunz // Vaccine. - 2000. -
Vol. 21, (suppl 1 ) . - P. 50-55.
399. Lang, T. Twenty statistical errors even you can find in biomedical research articles /
T. Lang // Croat. Med. J. - 2004. - Vol. 45, № 4. - P. 361-370.
400. Lau, J. Quantitative synthesis in systematic reviews / J. Lau, J. P. Ioannidis,
С. H. Schmid // Ann. Intern. Med. - 1997. - Vol. 127. - P. 820-826.
401. Lee, M. L. Use of intravenous immunoglobulin to prevent or treat infections in
persons with immune deficiency / M. L. Lee, R. P. Gale, P. L. Yap // Annu. Rev.
Med - 1997. - Vol. 48. - P. 93-102.
402. Lefrancois, L. The interaction of antibody with the major surface glycoprotein of
vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal
antibodies / L. Lefrancois, D. S. Lyles // Virology. - 1982. - Vol. 121. -
P. 157-167.
403. Lloyd-Evans, P. Expression of neutralizing recombinant human antibodies against
Varicella Zoster virus for use as a potential prophylactic / P. Lloyd-Evans,
J. E. Gilmour // Hybridoma. - 2000. - Vol. 19. - P. 143-149.
404. Lontai, I. Tick-borne encephalitis and its prevention inHungary / 1. Lontai, I. Straub//
Med. Pregl.- 1998.-Vol. 51, suppl. l . - P . 21-30.
405. Marasco, W. A. The growth and potential of human antiviral monoclonal antibody /
W. A. Marasco, J. Sui // Nature Biotechnology. - 2007. - Vol. 25, № 12. -
P. 1421-1434.
406. McCullough, R.C. The standardization of a spot-test ELISA for the rapid screening
of sera and hybridoma cell products. I. The determination of the optimum
buttering system / R. C. McCullough // J. Biol. Standard. - 1984. - Vol. 12, № 1. -
P. 67-74.
407. Mechanism of therapeutic effect of high dose intravenous immunoglobulin.
Attenuation of acute, complement-mediated immune damage in guinea pig model /
M. Basta [et al.] // J. Clin. Invest. - 1989. - Vol. 84. - P. 1974-1981.
408. Molecular and Biological Characterization of Human Monoclonal Antibodies
Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory
225